Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leiv Ose

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Clinical Cardiology|December 3, 2003
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroupsMichael H Davidson, Leiv Ose, Jiri Frohlich, et al.
Plos One|November 19, 2013
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotypeKirsten B Holven, Kjetil Retterstøl, Thor Ueland, et al.
The Journal of Nutrition|March 22, 2006
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol effluxInger O Ottestad, Bente Halvorsen, Trude R Balstad, et al.
Heart (British Cardiac Society)|April 7, 2018
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemiaLiv J Mundal, Jannicke Igland, Marit B Veierød, et al.
Thrombosis Research|December 4, 2012
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FHIngunn Narverud, Per Ole Iversen, Pål Aukrust, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTESKirsten B Holven, Jan K Damås, Arne Yndestad, et al.
JAMA|March 19, 2009
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trialMarijn C Meuwese, Eric de Groot, Raphaël Duivenvoorden, et al.
Atherosclerosis|September 20, 2015
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemiaIngunn Narverud, Jeanine Roeters van Lennep, Jacob J Christensen, et al.
Circulation|October 23, 2002
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatinSaskia de Jongh, Leiv Ose, Tamás Szamosi, et al.
European Heart Journal|May 27, 2015
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Samuel S Gidding, Gerald F Watts, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Cardiology|December 3, 2003
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroupsMichael H Davidson, Leiv Ose, Jiri Frohlich, et al.
Plos One|November 19, 2013
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotypeKirsten B Holven, Kjetil Retterstøl, Thor Ueland, et al.
The Journal of Nutrition|March 22, 2006
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol effluxInger O Ottestad, Bente Halvorsen, Trude R Balstad, et al.
Heart (British Cardiac Society)|April 7, 2018
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemiaLiv J Mundal, Jannicke Igland, Marit B Veierød, et al.
Thrombosis Research|December 4, 2012
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FHIngunn Narverud, Per Ole Iversen, Pål Aukrust, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 29, 2005
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTESKirsten B Holven, Jan K Damås, Arne Yndestad, et al.
JAMA|March 19, 2009
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trialMarijn C Meuwese, Eric de Groot, Raphaël Duivenvoorden, et al.
Atherosclerosis|September 20, 2015
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemiaIngunn Narverud, Jeanine Roeters van Lennep, Jacob J Christensen, et al.
Circulation|October 23, 2002
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatinSaskia de Jongh, Leiv Ose, Tamás Szamosi, et al.
European Heart Journal|May 27, 2015
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentAlbert Wiegman, Samuel S Gidding, Gerald F Watts, et al.
Pageof 8